Efficacy and Safety of Telitacicept in Early SLE

Clinical trial NCT05899907 · UNKNOWN

Trial details

NCT number: NCT05899907
Sponsor: Peking Union Medical College Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Lupus Erythematosus, Systemic

Start date: 2022-09-01
Primary completion: 2025-03-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.